{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:16:57Z","timestamp":1791649017154,"version":"4.3.4"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ejpb.2021.09.009","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T16:00:49Z","timestamp":1632758449000},"page":"90-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["The effect of buffer species on biorelevant dissolution and precipitation assays \u2013 Comparison of phosphate and bicarbonate buffer"],"prefix":"10.1016","volume":"171","author":[{"given":"Katharina","family":"Krollik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Kaidas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Kubas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Weitschies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ejpb.2021.09.009_b0005","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.addr.2007.05.007","article-title":"High throughput solubility measurement in drug discovery and development","volume":"59","author":"Alsenz","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2021.09.009_b0010","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1023\/A:1011910801212","article-title":"Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs","volume":"15","author":"Galia","year":"1998","journal-title":"Pharm. Res."},{"issue":"7","key":"10.1016\/j.ejpb.2021.09.009_b0015","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","article-title":"Dissolution media simulating conditions in the proximal human gastrointestinal tract: An update","volume":"25","author":"Jantratid","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2021.09.009_b0020","first-page":"229","volume":"94","author":"Fuchs","year":"2015","journal-title":"Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3, European journal of pharmaceutics and biopharmaceutics official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V"},{"issue":"3","key":"10.1016\/j.ejpb.2021.09.009_b0025","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ejpb.2005.03.002","article-title":"Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds","volume":"60","author":"Vertzoni","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2021.09.009_b0030","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1002\/jps.24183","article-title":"Composition and physicochemical properties of fasted-state human duodenal and jejunal fluid: A critical evaluation of the available data","volume":"103","author":"Fuchs","year":"2014","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.ejpb.2021.09.009_b0035","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s11095-016-1882-8","article-title":"Characteristics of the Human Upper Gastrointestinal Contents in the Fasted State Under Hypo- and A-chlorhydric Gastric Conditions Under Conditions of Typical Drug - Drug Interaction Studies","volume":"33","author":"Litou","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2021.09.009_b0040","doi-asserted-by":"crossref","unstructured":"M. La Perez de Cruz Moreno, M. Oth, S. Deferme, F. Lammert, J. Tack, J. Dressman, P. Augustijns, Characterization of fasted-state human intestinal fluids collected from duodenum and jejunum, The Journal of pharmacy and pharmacology 58 (2006) 1079\u20131089.","DOI":"10.1211\/jpp.58.8.0009"},{"issue":"1","key":"10.1016\/j.ejpb.2021.09.009_b0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11095-005-8476-1","article-title":"Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability\/bioequivalence studies","volume":"23","author":"Kalantzi","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2021.09.009_b0050","first-page":"173","article-title":"Early pharmaceutical profiling to predict oral drug absorption: Current status and unmet needs, European journal of pharmaceutical sciences official journal of the European Federation for","volume":"57","author":"Bergstr\u00f6m","year":"2014","journal-title":"Pharmaceutical Sciences"},{"issue":"12","key":"10.1016\/j.ejpb.2021.09.009_b0055","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s11095-005-8192-x","article-title":"The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluids","volume":"22","author":"Persson","year":"2005","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.ejpb.2021.09.009_b0060","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1021\/mp100198q","article-title":"Drug solubility in luminal fluids from different regions of the small and large intestine of humans","volume":"7","author":"Fadda","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2021.09.009_b0065","doi-asserted-by":"crossref","unstructured":"M. Vertzoni, N. Fotaki, E. Kostewicz, E. Stippler, C. Leuner, E. Nicolaides, J. Dressman, C. Reppas, Dissolution media simulating the intralumenal composition of the small intestine: Physiological issues and practical aspects, The Journal of pharmacy and pharmacology 56 (2004) 453\u2013462.","DOI":"10.1211\/0022357022935"},{"key":"10.1016\/j.ejpb.2021.09.009_b0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1011984216775","article-title":"Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms","volume":"5","author":"Dressman","year":"1998","journal-title":"Pharm Res"},{"key":"10.1016\/j.ejpb.2021.09.009_b0075","doi-asserted-by":"crossref","unstructured":"F. Karkossa, S. Klein, Assessing the influence of media composition and ionic strength on drug release from commercial immediate-release and enteric-coated aspirin tablets, The Journal of pharmacy and pharmacology 69 (2017) 1327\u20131340.","DOI":"10.1111\/jphp.12777"},{"issue":"4","key":"10.1016\/j.ejpb.2021.09.009_b0080","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1172\/JCI106561","article-title":"Acute undifferentiated human diarrhea in the tropics. II. Alterations in intestinal fluid and electrolyte","volume":"50","author":"Banwell","year":"1971","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.ejpb.2021.09.009_b0085","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0021-9258(18)45087-9","article-title":"The carbon dioxide tension and acid-base balance of jejunal secretions in man","volume":"142","author":"McGee","year":"1942","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejpb.2021.09.009_b0090","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1023\/A:1012107801889","article-title":"Characterization of fluids from the stomach and proximal jejunum in men and women","volume":"14","author":"Lindahl","year":"1997","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.ejpb.2021.09.009_b0095","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1208\/s12248-010-9203-3","article-title":"The use of biorelevant dissolution media to forecast the in vivo performance of a drug","volume":"12","author":"Klein","year":"2010","journal-title":"The AAPS journal"},{"key":"10.1016\/j.ejpb.2021.09.009_b0100","first-page":"105138","article-title":"Dissolution behavior of various drugs in different FaSSIF versions, European journal of pharmaceutical sciences official journal of the European Federation for","volume":"142","author":"Klumpp","year":"2020","journal-title":"Pharmaceutical Sciences"},{"key":"10.1016\/j.ejpb.2021.09.009_b0105","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1021\/mp100144v","article-title":"Simulating fasted human intestinal fluids: Understanding the roles of lecithin and bile acids","volume":"7","author":"S\u00f6derlind","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2021.09.009_b0110","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2036.1994.tb00319.x","article-title":"Review article: Gastroduodenal bicarbonate secretion","volume":"8","author":"Hogan","year":"1994","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2021.09.009_b0115","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1002\/jps.24108","article-title":"In vivo predictive dissolution: Transport analysis of the CO2 bicarbonate in vivo buffer system","volume":"103","author":"Krieg","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.09.009_b0120","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1021\/acs.molpharmaceut.9b00187","article-title":"Mass Transport Analysis of Bicarbonate Buffer: Effect of the CO2-H2CO3 Hydration-Dehydration Kinetics in the Fluid Boundary Layer and the Apparent Effective p Ka Controlling Dissolution of Acids and Bases","volume":"16","author":"Al-Gousous","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2021.09.009_b0125","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1021\/acs.molpharmaceut.8b00783","article-title":"Mass Transport Analysis of the Enhanced Buffer Capacity of the Bicarbonate-CO2 Buffer in a Phase-Heterogenous System: Physiological and Pharmaceutical Significance","volume":"15","author":"Al-Gousous","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2021.09.009_b0130","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1002\/jps.24460","article-title":"In Vivo Predictive Dissolution: Comparing the Effect of Bicarbonate and Phosphate Buffer on the Dissolution of Weak Acids and Weak Bases","volume":"104","author":"Krieg","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.09.009_b0135","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1023\/A:1026147620304","article-title":"Use of a physiologic bicarbonate buffer system for dissolution characterization of ionizable drugs","volume":"20","author":"McNamara","year":"2003","journal-title":"Pharm Res"},{"key":"10.1016\/j.ejpb.2021.09.009_b0140","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/jps.2600700103","article-title":"Dissolution kinetics of carboxylic acids I: effect of pH under unbuffered conditions","volume":"70","author":"Mooney","year":"1981","journal-title":"J. Pharm. Sci."},{"issue":"14-16","key":"10.1016\/j.ejpb.2021.09.009_b0145","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.3109\/03639048909052535","article-title":"Influence of the Buffering Capacity of the Medium on the Dissolution of Drug-Excipient Mixtures","volume":"15","author":"Ramtoola","year":"1989","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2021.09.009_b0150","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1021\/mp800148u","article-title":"Toward an in vivo dissolution methodology: A comparison of phosphate and bicarbonate buffers","volume":"6","author":"Sheng","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2021.09.009_b0155","first-page":"104","volume":"103","author":"Cristofoletti","year":"2016"},{"key":"10.1016\/j.ejpb.2021.09.009_b0160","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1208\/s12248-020-0417-8","article-title":"Selection of In Vivo Predictive Dissolution Media Using Drug Substance and Physiological Properties","volume":"22","author":"Mudie","year":"2020","journal-title":"The AAPS journal"},{"key":"10.1016\/j.ejpb.2021.09.009_b0165","first-page":"8","volume":"142","author":"Amaral Silva","year":"2019"},{"issue":"9","key":"10.1016\/j.ejpb.2021.09.009_b0170","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1021\/acs.molpharmaceut.9b00534","article-title":"Improved Prediction of in Vivo Supersaturation and Precipitation of Poorly Soluble Weakly Basic Drugs Using a Biorelevant Bicarbonate Buffer in a Gastrointestinal Transfer Model","volume":"16","author":"Jede","year":"2019","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2021.09.009_b0175","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1208\/s12249-013-9933-5","article-title":"An automated system for monitoring and regulating the pH of bicarbonate buffers","volume":"14","author":"Garbacz","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2021.09.009_b0180","first-page":"224","article-title":"A dynamic system for the simulation of fasting luminal pH-gradients using hydrogen carbonate buffers for dissolution testing of ionisable compounds, European journal of pharmaceutical sciences official journal of the European Federation for","volume":"51","author":"Garbacz","year":"2014","journal-title":"Pharmaceutical Sciences"},{"key":"10.1016\/j.ejpb.2021.09.009_b0185","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ijpharm.2014.09.003","article-title":"Predicting the gastrointestinal behaviour of modified-release products: Utility of a novel dynamic dissolution test apparatus involving the use of bicarbonate buffers","volume":"475","author":"Merchant","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2021.09.009_b0190","first-page":"94","volume":"115","author":"Litou","year":"2017"},{"key":"10.1016\/j.ejpb.2021.09.009_b0195","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. Roy. Stat. Soc.: Ser. B (Methodol.)"},{"key":"10.1016\/j.ejpb.2021.09.009_b0200","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.2042-7158.1972.tb08930.x","article-title":"Letters to the Editor: Linearization of dissolution rate curves by the Weibull distribution","volume":"24","author":"Langenbucher","year":"1972","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.ejpb.2021.09.009_b0205","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1115\/1.4010337","article-title":"A Statistical Distribution Function of Wide Applicability","volume":"18","author":"Weibull","year":"1951","journal-title":"J. Appl. Mech."},{"issue":"2","key":"10.1016\/j.ejpb.2021.09.009_b0210","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1-3","key":"10.1016\/j.ejpb.2021.09.009_b0215","first-page":"15","volume":"39","author":"Annaert","year":"2010","journal-title":"Pharmaceutical Sciences"},{"key":"10.1016\/j.ejpb.2021.09.009_b0220","first-page":"322","article-title":"A review of drug solubility in human intestinal fluids: Implications for the prediction of oral absorption, European journal of pharmaceutical sciences official journal of the European Federation for","volume":"57","author":"Augustijns","year":"2014","journal-title":"Pharmaceutical Sciences"},{"issue":"4","key":"10.1016\/j.ejpb.2021.09.009_b0225","first-page":"260","article-title":"Intestinal drug solubility estimation based on simulated intestinal fluids: Comparison with solubility in human intestinal fluids, European journal of pharmaceutical sciences official journal of the European Federation for","volume":"43","author":"Clarysse","year":"2011","journal-title":"Pharmaceutical Sciences"},{"issue":"6","key":"10.1016\/j.ejpb.2021.09.009_b0230","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1007\/s11095-009-9857-7","article-title":"Postprandial changes in solubilizing capacity of human intestinal fluids for BCS class II drugs","volume":"26","author":"Clarysse","year":"2009","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.ejpb.2021.09.009_b0235","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1021\/mp100377m","article-title":"Excipient-mediated supersaturation stabilization in human intestinal fluids","volume":"8","author":"Bevernage","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2021.09.009_b0240","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2174\/138920007780866799","article-title":"Evaluation of human pharmacokinetics, therapeutic dose and exposure predictions using marketed oral drugs","volume":"8","author":"McGinnity","year":"2007","journal-title":"Curr. Drug Metab."},{"issue":"1","key":"10.1016\/j.ejpb.2021.09.009_b0245","doi-asserted-by":"crossref","DOI":"10.5599\/admet.2.1.31","article-title":"Phosphate Precipitates and Water-Soluble Aggregates in Re-analyzed Solubility-pH Data of Twenty-five Basic Drugs","volume":"2","author":"Avdeef","year":"2014","journal-title":"ADMET DMPK"},{"issue":"2","key":"10.1016\/j.ejpb.2021.09.009_b0250","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1021\/la962060h","article-title":"Liquid Crystals and Colloids in Water\u2212Amiodarone Systems","volume":"14","author":"Bouligand","year":"1998","journal-title":"Langmuir"},{"issue":"11","key":"10.1016\/j.ejpb.2021.09.009_b0255","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/jps.2600641117","article-title":"Micelle formation and its relationship to solubility behavior of 2-butyl-3-benzofuranyl-4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl ketone hydrochloride","volume":"64","author":"Ravin","year":"1975","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.09.009_b0260","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/jps.2600581018","article-title":"Effect of polysorbate 80 on the solubility and in vivo availability of 2-butyl-3-benzofuranyl 4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl ketone hydrochloride (SK&F 33134-a)","author":"Ravin","year":"1969","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.09.009_b0265","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1093\/ajhp\/52.20.2340","article-title":"Incompatibility of amiodarone hydrochloride and sodium bicarbonate injections","volume":"52","author":"Korth-Bradley","year":"1995","journal-title":"American journal of health-system pharmacy AJHP official journal of the American Society of Health-System Pharmacists"},{"issue":"1-3","key":"10.1016\/j.ejpb.2021.09.009_b0270","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0378-5173(86)90055-4","article-title":"Salt selection for basic drugs","volume":"33","author":"Gould","year":"1986","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/j.ejpb.2021.09.009_b0275","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.addr.2007.05.010","article-title":"Salt formation to improve drug solubility","volume":"59","author":"Serajuddin","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2021.09.009_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2019.101492","article-title":"Effect of buffer capacity on dissolution and supersaturation profiles of pioglitazone hydrochloride","volume":"55","author":"Uekusa","year":"2020","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ejpb.2021.09.009_b0285","doi-asserted-by":"crossref","unstructured":"T.C. Machado, G. Kuminek, S.G. Cardoso, N. Rodr\u00edguez-Hornedo, The role of pH and dose\/solubility ratio on cocrystal dissolution, drug supersaturation and precipitation, European journal of pharmaceutical sciences official journal of the European Federation for Pharmaceutical Sciences (2020) 105422.","DOI":"10.1016\/j.ejps.2020.105422"},{"issue":"3","key":"10.1016\/j.ejpb.2021.09.009_b0290","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/(SICI)1520-6017(200003)89:3<382::AID-JPS9>3.0.CO;2-H","article-title":"Wetting properties of bile salt solutions and dissolution media","volume":"89","author":"Luner","year":"2000","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2021.09.009_b0295","doi-asserted-by":"crossref","first-page":"6","DOI":"10.14227\/DT260219P6","article-title":"Stability of Biorelevant Media Under Various Storage Conditions","volume":"26","author":"Klumpp","year":"2019","journal-title":"Dissolution Technol."},{"key":"10.1016\/j.ejpb.2021.09.009_b0300","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1039\/df9572400141","article-title":"A new approach to the study of hydration of ions in aqueous solutions","volume":"24","author":"Samoilov","year":"1957","journal-title":"Discuss. Faraday Soc."},{"issue":"48","key":"10.1016\/j.ejpb.2021.09.009_b0305","doi-asserted-by":"crossref","first-page":"13570","DOI":"10.1021\/jp075913v","article-title":"Hydration of sodium, potassium, and chloride ions in solution and the concept of structure maker\/breaker","volume":"111","author":"Mancinelli","year":"2007","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejpb.2021.09.009_b0310","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/(SICI)1520-6017(200002)89:2<268::AID-JPS14>3.0.CO;2-F","article-title":"Dissolution of Ionizable Water-Insoluble Drugs: The Combined Effect of pH and Surfactant","volume":"89","author":"Jinno","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.09.009_b0315","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11095-019-2731-3","article-title":"Measuring pH and Buffer Capacity in Fluids Aspirated from the Fasted Upper Gastrointestinal Tract of Healthy Adults","volume":"37","author":"Litou","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2021.09.009_b0320","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ijpharm.2017.05.072","article-title":"Exploring drug solubility in fasted human intestinal fluid aspirates: Impact of inter-individual variability, sampling site and dilution","volume":"528","author":"de La Cruz-Moreno","year":"2017","journal-title":"Int. J. Pharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121002538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121002538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:46:36Z","timestamp":1760546796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641121002538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":64,"alternative-id":["S0939641121002538"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.09.009","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of buffer species on biorelevant dissolution and precipitation assays \u2013 Comparison of phosphate and bicarbonate buffer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}